Remidex Pharma Private Limited - Company Profile

It is a pharma private limited company based in Bengaluru, Karnataka, India, established in 1981.
1981 Bengaluru, Karnataka, India Active
Last Updated:
Access Report
About Remidex Pharma Private Limited

Remidex Pharma Private Limited, a active private limited company, was established on 15 June 1981 in Bengaluru, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231KA1981PTC004260. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹3.00 Cr.

It upholds a compliant status. Employing 123 professional, Its leadership includes Ishaan Pejavar Rao (Director), Nandan Pejavar Rao (Director), Nilima Dayanand Rao (Managing Director). Past directors included Seegakula Sathyanarayana Setty, Namagundlu Bhaskarasastry Vishwanath, Venkatram Subramony. It holds ₹4.00 Cr open charges and ₹15.26 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at B-249,250,147&148, 6Th Main 2Nd Stage, Peenya Industrial Estate, Bengaluru, Karnataka, 560058.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231KA1981PTC004260

  • Registration Number

    004260

  • Incorporation Date

    15 June 1981

  • Authorized Capital

    ₹3.00 Cr

  • Paid-Up Capital

    ₹3.00 Cr

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.00 Cr
  • Paid Up Capital ₹ 3.00 Cr
  • Company Age 44 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 4.00 Cr
  • Satisfied Charges ₹ 15.26 Cr
  • Revenue Growth **** 0.34%
  • Profit Growth **** 41.79%
  • Ebitda **** 52.02%
  • Net Worth -42.10%
  • Total Assets -7.61%
Company report

Remidex Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Remidex Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Remidex Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Ishaan Pejavar Rao Director 24 Oct 2018 Current
Nandan Pejavar Rao Director 24 Oct 2018 Current
Nilima Dayanand Rao Managing Director 24 Jan 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 18 May 2011 Past
Pramod Abcsdd Director 31 Oct 2008 Past
Pramod Abcsdd Director 22 Dec 2018 Past
Pramod Abcsdd Director 11 Jun 2020 Past
Pramod Abcsdd Director 05 Dec 2018 Past
Pramod Abcsdd Director 29 Oct 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Remidex Pharma.

Remidex Pharma Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 0.34% increase. The company also saw a substantial improvement in profitability, with a 41.79% increase in profit. The company's net worth observed a substantial decline by a decrease of 42.1%.

Remidex Pharma revenue growth over time
Remidex Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 0.34%
*******
*******
*******
*******
Revenue from Operations
*******
 2.08%
*******
*******
*******
*******
Total Assets
*******
 -7.61%
*******
*******
*******
*******
Profit or Loss
*******
 41.79%
*******
*******
*******
*******
Net Worth
*******
 -42.10%
*******
*******
*******
*******
EBITDA
*******
 52.02%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Remidex Pharma?

Unlock access to Remidex Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹40,000,000.00

Satisfied Charges

₹152,550,000.00

Charges Breakdown by Lending Institutions
  • Canara Bank : 4.00 Cr
Latest Charge Details
Date Lender Amount Status
16 Apr 2006 Canara Bank ₹4.00 Cr Open
21 Aug 2019 Others ₹6.00 Cr Satisfied
20 Jul 2018 Canara Bank ₹3.10 M Satisfied
29 Jan 2005 Kotak Mahindra Bank Ltd ₹1.95 Cr Satisfied
29 Jan 2005 Kotak Mahindra Bank Limited ₹3.35 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Remidex Pharma?

Remidex Pharma has a workforce of 123 employees as of Mar 21, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Remidex Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Remidex Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Remidex Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Remidex Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Charges

    The activity A charge with Canara Bank of Rs. 4.00 Cr registered on 16 Apr 2006 with Charge ID 80047323 was modified on 09 Sep 2025. was completed.

  • Balance Sheet

    Progress on Remidex Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was documented.

  • Charges

    The activity A charge registered on 20 Jul 2018 via Charge ID 100241950 with Canara Bank was fully satisfied on 20 Jan 2022. was completed.

  • Charges

    A charge registered on 16 May 1998 via Charge ID 90191951 with Canara Bank was fully satisfied on 19 Jun 2020. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 14 Nov 1997 via Charge ID 90191869 with Canara Bank was fully satisfied on 19 Jun 2020. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Remidex Pharma Private Limited?

The CIN of Remidex Pharma Private Limited is U24231KA1981PTC004260.

Where is Remidex Pharma Private Limited headquartered?

Remidex Pharma Private Limited is headquartered at B-249,250,147&148, 6Th Main 2Nd Stage, Peenya Industrial Estate, Bengaluru, Karnataka, 560058.

When was Remidex Pharma Private Limited incorporated?

Remidex Pharma Private Limited was incorporated on 15 June 1981.

Who are the current directors of Remidex Pharma Private Limited?

The current directors of Remidex Pharma Private Limited are

What is the primary industry of Remidex Pharma Private Limited?

The primary industry of Remidex Pharma Private Limited is Manufacturing.

Is Remidex Pharma Private Limited a listed company?

Remidex Pharma Private Limited is unlisted.

What is the capital structure of Remidex Pharma Private Limited?

The authorized capital of Remidex Pharma Private Limited is ₹3.00 Cr, and the paid-up capital is ₹3.00 Cr.

What is the compliance status of Remidex Pharma Private Limited?

The compliance status of Remidex Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available